Trial Profile
The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2023
Price :
$35
*
At a glance
- Drugs Midodrine (Primary) ; Mirabegron (Primary) ; Pyridostigmine (Primary)
- Indications Orthostatic hypotension; Spinal cord injuries
- Focus Therapeutic Use
- 23 Jun 2023 Status changed from recruiting to completed.
- 10 Feb 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2021.
- 10 Feb 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2021.